R&D Systems™ Recombinant Human IL-17RD/SEF Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-17 RD/SEF Protein is derived from NS0. The Recombinant Human IL-17 RD/SEF Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 54756
• Molecular Weight (g/mol): 32 kDa
• Name: IL-17RD/SEF
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human IL-17 RD/SEF protein Ala27-Arg299,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: FLJ35755, IL-17 RD, IL17RD, IL-17RDIL-17 receptor D, IL17Rhom, IL17RLM, IL17RLMDKFZp434N1928, interleukin 17 receptor D, interleukin-17 receptor D, Interleukin-17 receptor-like protein, MGC133309, SEF, Sef homolog, SEFhSef
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.